Φορτώνει......
New Antihyperglycemic Drugs and Heart Failure: Synopsis of Basic and Clinical Data
The assessment of the cardiovascular safety profile of any newly developed antihyperglycemic drug is mandatory before registration, as a meta-analysis raised alarm describing a significant increase in myocardial infarction with the thiazolidinedione rosiglitazone. The first results from completed ca...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Biomed Res Int |
|---|---|
| Κύριοι συγγραφείς: | , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Hindawi
2017
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5574229/ https://ncbi.nlm.nih.gov/pubmed/28894748 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/1253425 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|